APC 366 TFA structure 
             | 
        Common Name | APC 366 TFA | ||
|---|---|---|---|---|
| CAS Number | 2421110-28-1 | Molecular Weight | 554.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H29F3N6O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
            Use of APC 366 TFAAPC 366 (TFA) is an irreversible mast cell tryptase inhibitor. APC 366 (TFA) can be used for the research of allergic diseases[1].  | 
    
| Name | APC 366 TFA | 
|---|
| Description | APC 366 (TFA) is an irreversible mast cell tryptase inhibitor. APC 366 (TFA) can be used for the research of allergic diseases[1]. | 
|---|---|
| Related Catalog | |
| Target | 
                                    
                                     mast cell tryptase[1]  | 
                            
| In Vivo | APC 366 (TFA) (5 mg/kg/0.1 ml; s.c.) reduces the eosinophil recruitment induced by PAR-2 activating peptide[1]. Animal Model: Male BALB/c mice (18–25 g)[1] Dosage: 5 mg/kg/0.1 ml Administration: S.c. Result: Reduced the eosinophil recruitment induced by PAR-2 activating peptide. | 
| References | 
| Molecular Formula | C24H29F3N6O6 | 
|---|---|
| Molecular Weight | 554.52 |